G305-1214 Screening compound: N-(4-methyl-1,3-thiazol-2-yl)-1-[(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide

G305-1214 Screening compound: N-(4-methyl-1,3-thiazol-2-yl)-1-[(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide
G305-1214 Screening compound: N-(4-methyl-1,3-thiazol-2-yl)-1-[(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G305-1214
N-(4-methyl-1,3-thiazol-2-yl)-1-[(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G305-1214

Molecular Formula

C17H18N4O5S2 (C17 H18 N4 O5 S2)

Compound Name

N-(4-methyl-1,3-thiazol-2-yl)-1-[(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide

IUPAC name

N-(4-methyl-13-thiazol-2-yl)-1-[(2-oxo-23-dihydro-13-benzoxazol-6-yl)sulfonyl]piperidine-3-carboxamide

SMILES

Cc1csc(NC(C(CCC2)CN2S(c(cc2)cc(O3)c2NC3=O)(=O)=O)=O)n1

InChI

InChI=1S/C17H18N4O5S2/c1-10-9-27-16(18-10)20-15(22)11-3-2-6-21(8-11)28(24,25)12-4-5-13-14(7-12)26-17(23)19-13/h4-5,7,9,11H,2-3,6,8H2,1H3,(H,19,23)(H,18,20,22)/t11-/m0/s1

InChI Key

RLSBFOGCDGDNHH-NSHDSACASA-N

MDL Number (MFCD)

MFCD14996134

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

422.49

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.735

Distribution Coefficient, logD

1.616

Water Solubility, LogSw

-2.55

Polar Surface Area

98.245

Acid Dissociation Constant (pKa)

7.90

Base Dissociation Constant (pKb)

2.10

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

35.30

G305-1214 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with G305-1214 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G305-1214?
Check Price and Availability of G305-1214, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G305-1214 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G305-1214
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G305-1214
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G305-1214 available by request